Found 8 hits for monomerid = 50352121 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM50352121
(CHEMBL1824511 | CHEMBL1852555)Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)CCc1ccncc1 |r| Show InChI InChI=1S/C28H33N3O4/c32-21-5-4-19-15-22-28(34)10-7-20(30-23(33)6-3-17-8-12-29-13-9-17)26-27(28,24(19)25(21)35-26)11-14-31(22)16-18-1-2-18/h4-5,8-9,12-13,18,20,22,26,32,34H,1-3,6-7,10-11,14-16H2,(H,30,33)/t20-,22-,26+,27+,28-/m1/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.570 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Virginia Commonwealth University
Curated by ChEMBL
| Assay Description Displacement of [3H]naloxone from mu opioid receptor expressed in CHO cells after 1 hr |
Bioorg Med Chem Lett 21: 5625-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.06.135 BindingDB Entry DOI: 10.7270/Q21J9B57 |
More data for this Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM50352121
(CHEMBL1824511 | CHEMBL1852555)Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)CCc1ccncc1 |r| Show InChI InChI=1S/C28H33N3O4/c32-21-5-4-19-15-22-28(34)10-7-20(30-23(33)6-3-17-8-12-29-13-9-17)26-27(28,24(19)25(21)35-26)11-14-31(22)16-18-1-2-18/h4-5,8-9,12-13,18,20,22,26,32,34H,1-3,6-7,10-11,14-16H2,(H,30,33)/t20-,22-,26+,27+,28-/m1/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.570 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Virginia Commonwealth University
Curated by ChEMBL
| Assay Description Displacement of [3H]Naloxone from mu opioid receptor expressed in CHO cells after 1 hr |
J Med Chem 55: 10118-29 (2012)
Article DOI: 10.1021/jm301247n BindingDB Entry DOI: 10.7270/Q29P32SK |
More data for this Ligand-Target Pair | |
Kappa-type opioid receptor
(Homo sapiens (Human)) | BDBM50352121
(CHEMBL1824511 | CHEMBL1852555)Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)CCc1ccncc1 |r| Show InChI InChI=1S/C28H33N3O4/c32-21-5-4-19-15-22-28(34)10-7-20(30-23(33)6-3-17-8-12-29-13-9-17)26-27(28,24(19)25(21)35-26)11-14-31(22)16-18-1-2-18/h4-5,8-9,12-13,18,20,22,26,32,34H,1-3,6-7,10-11,14-16H2,(H,30,33)/t20-,22-,26+,27+,28-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Virginia Commonwealth University
Curated by ChEMBL
| Assay Description Displacement of [3H]DPN from kappa opioid receptor expressed in CHO cells after 1 hr |
J Med Chem 55: 10118-29 (2012)
Article DOI: 10.1021/jm301247n BindingDB Entry DOI: 10.7270/Q29P32SK |
More data for this Ligand-Target Pair | |
Kappa-type opioid receptor
(Homo sapiens (Human)) | BDBM50352121
(CHEMBL1824511 | CHEMBL1852555)Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)CCc1ccncc1 |r| Show InChI InChI=1S/C28H33N3O4/c32-21-5-4-19-15-22-28(34)10-7-20(30-23(33)6-3-17-8-12-29-13-9-17)26-27(28,24(19)25(21)35-26)11-14-31(22)16-18-1-2-18/h4-5,8-9,12-13,18,20,22,26,32,34H,1-3,6-7,10-11,14-16H2,(H,30,33)/t20-,22-,26+,27+,28-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Virginia Commonwealth University
Curated by ChEMBL
| Assay Description Displacement of [3H]-norBNI from kappa opioid receptor expressed in CHO cells after 1 hr |
Bioorg Med Chem Lett 21: 5625-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.06.135 BindingDB Entry DOI: 10.7270/Q21J9B57 |
More data for this Ligand-Target Pair | |
Delta-type opioid receptor
(Homo sapiens (Human)) | BDBM50352121
(CHEMBL1824511 | CHEMBL1852555)Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)CCc1ccncc1 |r| Show InChI InChI=1S/C28H33N3O4/c32-21-5-4-19-15-22-28(34)10-7-20(30-23(33)6-3-17-8-12-29-13-9-17)26-27(28,24(19)25(21)35-26)11-14-31(22)16-18-1-2-18/h4-5,8-9,12-13,18,20,22,26,32,34H,1-3,6-7,10-11,14-16H2,(H,30,33)/t20-,22-,26+,27+,28-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 294 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Virginia Commonwealth University
Curated by ChEMBL
| Assay Description Displacement of [3H]NTI from delta opioid receptor expressed in CHO cells after 1 hr |
J Med Chem 55: 10118-29 (2012)
Article DOI: 10.1021/jm301247n BindingDB Entry DOI: 10.7270/Q29P32SK |
More data for this Ligand-Target Pair | |
Delta-type opioid receptor
(Homo sapiens (Human)) | BDBM50352121
(CHEMBL1824511 | CHEMBL1852555)Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)CCc1ccncc1 |r| Show InChI InChI=1S/C28H33N3O4/c32-21-5-4-19-15-22-28(34)10-7-20(30-23(33)6-3-17-8-12-29-13-9-17)26-27(28,24(19)25(21)35-26)11-14-31(22)16-18-1-2-18/h4-5,8-9,12-13,18,20,22,26,32,34H,1-3,6-7,10-11,14-16H2,(H,30,33)/t20-,22-,26+,27+,28-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 294 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Virginia Commonwealth University
Curated by ChEMBL
| Assay Description Displacement of [3H]-NTI from delta opioid receptor expressed in CHO cells after 1 hr |
Bioorg Med Chem Lett 21: 5625-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.06.135 BindingDB Entry DOI: 10.7270/Q21J9B57 |
More data for this Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM50352121
(CHEMBL1824511 | CHEMBL1852555)Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)CCc1ccncc1 |r| Show InChI InChI=1S/C28H33N3O4/c32-21-5-4-19-15-22-28(34)10-7-20(30-23(33)6-3-17-8-12-29-13-9-17)26-27(28,24(19)25(21)35-26)11-14-31(22)16-18-1-2-18/h4-5,8-9,12-13,18,20,22,26,32,34H,1-3,6-7,10-11,14-16H2,(H,30,33)/t20-,22-,26+,27+,28-/m1/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a |
Virginia Commonwealth University
Curated by ChEMBL
| Assay Description Displacement of [3H]naloxone from mu opioid receptor expressed in CHO cells after 1 hr |
Bioorg Med Chem Lett 21: 5625-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.06.135 BindingDB Entry DOI: 10.7270/Q21J9B57 |
More data for this Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM50352121
(CHEMBL1824511 | CHEMBL1852555)Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)CCc1ccncc1 |r| Show InChI InChI=1S/C28H33N3O4/c32-21-5-4-19-15-22-28(34)10-7-20(30-23(33)6-3-17-8-12-29-13-9-17)26-27(28,24(19)25(21)35-26)11-14-31(22)16-18-1-2-18/h4-5,8-9,12-13,18,20,22,26,32,34H,1-3,6-7,10-11,14-16H2,(H,30,33)/t20-,22-,26+,27+,28-/m1/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a |
Virginia Commonwealth University
Curated by ChEMBL
| Assay Description Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding |
J Med Chem 55: 10118-29 (2012)
Article DOI: 10.1021/jm301247n BindingDB Entry DOI: 10.7270/Q29P32SK |
More data for this Ligand-Target Pair | |